Skip to Content

Investors Tire of Energy, Think Chips Are Fab

Energy stocks performed poorly; semiconductor stocks did well.

Ask anyone who drives a car: gasoline prices are out of control. But that’s no shocker. The price of gas is a function of the price of oil, which, while having retreated from an April high of almost $60 a barrel, is still at a healthy $48. The good news: if the market lives up to its reputation as a dependable portent of the future, there may be more relief in sight, as energy stocks were some of the poorest performers in our indices in the month ending May 13. Every single energy stock in the TR Large-Cap 100 fell during the month, led by a 4.9 percent drop in Shell Transport and Trading (the minority partner in Shell Oil). The same did not hold true in the TR Small-Cap 50, but last month’s focus stock, First Calgary Petroleums, continued its journey downward, falling 14.2 percent.

Semiconductor stocks, on the other hand, are enjoying a deserved reprieve. The top gainers in both indices were chip stocks – Texas Instruments and Japanese upstart Ibiden – but they were joined on the way up by most of their industry brethren. The cause, interestingly, was less a preponderance of good news than a lack of bad news. Chip stocks famously move ahead of fundamental results, and with first-quarter reporting season having passed with no real blowups, many investors are clearly trying to get a leg up on those who wait till the writing’s on the wall.

In April, Clear Channel Communications announced plans to spin off its entertainment and venue-management business and sell a stake in its billboard-advertising division through an initial public offering. Investors were not pleased. Through May 13, the stock was down 25.5 percent from its 52-week high and was the biggest loser in the TR Large-Cap 100 for the month.

Keep Reading

Most Popular

This startup wants to copy you into an embryo for organ harvesting

With plans to create realistic synthetic embryos, grown in jars, Renewal Bio is on a journey to the horizon of science and ethics.

VR is as good as psychedelics at helping people reach transcendence

On key metrics, a VR experience elicited a response indistinguishable from subjects who took medium doses of LSD or magic mushrooms.

This nanoparticle could be the key to a universal covid vaccine

Ending the covid pandemic might well require a vaccine that protects against any new strains. Researchers may have found a strategy that will work.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.